| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.18 | 0.7 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |